- Corporate Officers - E
- Emster Kurt Von
Insider Trading History of Emster Kurt Von
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Emster Kurt Von since 2006.
This trader's CIK number is 1252524.
At the time of last reporting, Emster Kurt Von was the Director of Cymabay Therapeutics, Inc.. (stock ticker symbol CBAY).
Also see all insider trading activities at Cymabay Therapeutics, Inc..
Note that in the past
EMSTER KURT VON also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cymabay Therapeutics, Inc. (CBAY) by Emster Kurt Von
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | CBAY | 0 | $0 | 15,921 | $249,673 | 15,921 | $79,605 |
| 2018 | CBAY | 153,846 | $999,999 | 1,016,961 | $12,261,755 | 0 | $0 |
| 2017 | CBAY | 0 | $0 | 606,769 | $5,243,817 | 0 | $0 |
Yearly summary of insider trading at Vaxcyte, Inc. (PCVX) by Emster Kurt Von
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | PCVX | 12,500 | $200,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Somaxon Pharmaceuticals, Inc. (SOMX) by Emster Kurt Von
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | SOMX | 0 | $0 | 1,367 | $396 | 0 | $0 |
| 2010 | SOMX | 0 | $0 | 68,553 | $391,453 | 0 | $0 |
| 2007 | SOMX | 0 | $0 | 93,360 | $1,397,555 | 0 | $0 |
| 2006 | SOMX | 0 | $0 | 3,089 | $43,462 | 0 | $0 |
Yearly summary of insider trading at Jasper Therapeutics, Inc. (JSPR) by Emster Kurt Von
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | JSPR | 0 | $0 | 9,075 | $13,521 | 0 | $0 |
Yearly summary of insider trading at Crispr Therapeutics Ag (CRSP) by Emster Kurt Von
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | CRSP | 65,934 | $1,499,998 | 853,945 | $40,589,390 | 0 | $0 |
| 2017 | CRSP | 56,000 | $784,000 | 650,455 | $11,701,190 | 0 | $0 |
Insider trading activities at 5 companies by Emster Kurt Von:
1. Cymabay Therapeutics, Inc. (CBAY)
2. Vaxcyte, Inc. (PCVX)
3. Somaxon Pharmaceuticals, Inc. (SOMX)
4. Jasper Therapeutics, Inc. (JSPR)
5. Crispr Therapeutics Ag (CRSP)
Table 1. Insider trading of Cymabay Therapeutics, Inc. (CBAY) by Emster Kurt Von
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-09-29 | CBAY | Option Ex | 15,921 | 5.00 | 79,605 |
| 2023-09-29 | CBAY | Sale | 15,921 | 15.68 | 249,673 |
| 2018-12-18 | CBAY | Sale | 53,492 | 7.43 | 397,392 |
| 2018-12-17 | CBAY | Sale | 88,889 | 8.17 | 726,223 |
| 2018-06-05 | CBAY | Sale | 920 | 12.51 | 11,509 |
| 2018-03-05 | CBAY | Sale | 13,353 | 15.51 | 207,105 |
| 2018-02-15 | CBAY | Sale | 68,712 | 14.49 | 995,636 |
| 2018-02-13 | CBAY | Sale | 55,078 | 13.51 | 744,103 |
| 2018-02-14 | CBAY | Sale | 162,979 | 16.69 | 2,720,119 |
| 2017-07-19 | CBAY | Buy | 153,846 | 6.50 | 999,999 |
| 2018-02-07 | CBAY | Sale | 40,763 | 12.35 | 503,423 |
| 2018-02-05 | CBAY | Sale | 18,831 | 12.14 | 228,608 |
| 2018-02-02 | CBAY | Sale | 2,000 | 12.11 | 24,220 |
| 2018-02-01 | CBAY | Sale | 88,098 | 12.15 | 1,070,390 |
| 2018-01-30 | CBAY | Sale | 85,339 | 12.22 | 1,042,842 |
| 2018-01-31 | CBAY | Sale | 12,300 | 12.23 | 150,429 |
| 2018-01-25 | CBAY | Sale | 39,438 | 12.18 | 480,354 |
| 2018-01-22 | CBAY | Sale | 138,253 | 10.40 | 1,437,831 |
| 2018-01-18 | CBAY | Sale | 13,632 | 10.21 | 139,182 |
| 2018-01-19 | CBAY | Sale | 130,584 | 10.25 | 1,338,486 |
| 2018-01-05 | CBAY | Sale | 4,300 | 10.21 | 43,903 |
| 2017-12-22 | CBAY | Sale | 173,192 | 9.41 | 1,629,390 |
| 2017-11-10 | CBAY | Sale | 50,048 | 9.26 | 463,394 |
| 2017-11-01 | CBAY | Sale | 4,320 | 9.26 | 39,981 |
| 2017-10-31 | CBAY | Sale | 52,573 | 9.27 | 487,351 |
| 2017-10-30 | CBAY | Sale | 6,636 | 9.26 | 61,449 |
| 2017-10-02 | CBAY | Sale | 37,936 | 7.93 | 300,832 |
| 2017-10-03 | CBAY | Sale | 70,940 | 7.81 | 554,041 |
| 2017-09-28 | CBAY | Sale | 90,389 | 8.15 | 736,670 |
| 2017-09-29 | CBAY | Sale | 120,735 | 8.04 | 970,709 |
Table 2. Insider trading of Vaxcyte, Inc. (PCVX) by Emster Kurt Von
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-16 | PCVX | Buy | 12,500 | 16.00 | 200,000 |
Table 3. Insider trading of Somaxon Pharmaceuticals, Inc. (SOMX) by Emster Kurt Von
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-09-05 | SOMX | Sale | 1,367 | .29 | 396 |
| 2010-12-02 | SOMX | Sale | 26,000 | 2.78 | 72,306 |
| 2010-04-30 | SOMX | Sale | 42,553 | 7.50 | 319,147 |
| 2007-05-14 | SOMX | Sale | 36,300 | 14.80 | 537,385 |
| 2007-05-11 | SOMX | Sale | 32,060 | 14.62 | 468,845 |
| 2007-05-10 | SOMX | Sale | 25,000 | 15.65 | 391,325 |
| 2006-09-11 | SOMX | Sale | 3,089 | 14.07 | 43,462 |
Table 4. Insider trading of Jasper Therapeutics, Inc. (JSPR) by Emster Kurt Von
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-04-13 | JSPR | Sale | 9,075 | 1.49 | 13,521 |
Table 5. Insider trading of Crispr Therapeutics Ag (CRSP) by Emster Kurt Von
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-12-18 | CRSP | Sale | 69,925 | 29.70 | 2,077,122 |
| 2018-12-17 | CRSP | Sale | 3,009 | 33.17 | 99,796 |
| 2018-06-05 | CRSP | Sale | 920 | 12.51 | 11,509 |
| 2018-05-14 | CRSP | Sale | 400,000 | 54.43 | 21,773,200 |
| 2018-05-11 | CRSP | Sale | 250,000 | 52.51 | 13,128,250 |
| 2018-01-05 | CRSP | Buy | 65,934 | 22.75 | 1,499,998 |
| 2018-01-05 | CRSP | Sale | 92,337 | 26.96 | 2,489,405 |
| 2018-01-02 | CRSP | Sale | 37,754 | 26.75 | 1,010,108 |
| 2017-08-28 | CRSP | Sale | 88,011 | 19.79 | 1,741,737 |
| 2017-08-25 | CRSP | Sale | 14,913 | 19.52 | 291,101 |
| 2017-08-24 | CRSP | Sale | 7,868 | 19.23 | 151,301 |
| 2017-08-22 | CRSP | Sale | 10,954 | 18.53 | 202,977 |
| 2017-08-23 | CRSP | Sale | 7,035 | 18.53 | 130,358 |
| 2017-08-21 | CRSP | Sale | 1,250 | 18.51 | 23,137 |
| 2017-08-18 | CRSP | Sale | 1,900 | 18.53 | 35,207 |
| 2017-08-16 | CRSP | Sale | 20,548 | 19.27 | 395,959 |
| 2017-08-17 | CRSP | Sale | 13,593 | 18.74 | 254,732 |
| 2017-08-14 | CRSP | Sale | 29,983 | 19.64 | 588,866 |
| 2017-08-15 | CRSP | Sale | 25,586 | 19.53 | 499,694 |
| 2017-08-07 | CRSP | Sale | 15,623 | 18.53 | 289,494 |
| 2017-08-08 | CRSP | Sale | 19,850 | 18.71 | 371,393 |
| 2017-08-03 | CRSP | Sale | 47,409 | 17.77 | 842,457 |
| 2017-08-04 | CRSP | Sale | 3,068 | 18.50 | 56,758 |
| 2017-07-31 | CRSP | Sale | 5,248 | 17.51 | 91,871 |
| 2017-08-01 | CRSP | Sale | 264 | 17.50 | 4,620 |
| 2017-07-28 | CRSP | Sale | 400 | 17.65 | 7,059 |
| 2017-07-27 | CRSP | Sale | 40,912 | 17.62 | 721,074 |
| 2017-07-26 | CRSP | Sale | 23,744 | 17.63 | 418,606 |
| 2017-07-25 | CRSP | Sale | 9,186 | 17.52 | 160,938 |
| 2017-07-13 | CRSP | Sale | 33,629 | 16.87 | 567,321 |
| 2017-07-14 | CRSP | Sale | 36,230 | 16.82 | 609,388 |
| 2017-07-11 | CRSP | Sale | 14,120 | 16.52 | 233,262 |
| 2017-07-12 | CRSP | Sale | 17,872 | 16.60 | 296,675 |
| 2017-07-05 | CRSP | Sale | 4,254 | 16.26 | 69,170 |
| 2017-06-28 | CRSP | Sale | 31,592 | 17.04 | 538,327 |
| 2017-06-29 | CRSP | Sale | 11,610 | 16.52 | 191,797 |
| 2017-06-26 | CRSP | Sale | 48,001 | 16.83 | 807,856 |
| 2017-06-27 | CRSP | Sale | 33,434 | 17.43 | 582,754 |
| 2017-06-23 | CRSP | Sale | 30,841 | 16.23 | 500,549 |
| 2017-06-22 | CRSP | Sale | 1,527 | 16.21 | 24,752 |
| 2016-10-24 | CRSP | Buy | 56,000 | 14.00 | 784,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Emster Kurt Von
(Director of Cymabay Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.